Showing results (101-110 of 131) with videos related to
Sort By:
Pageof 14
Cell|January 29, 1993
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeA Aruffo, M Farrington, D Hollenbaugh, et al.Science (New York, N.Y.)|April 10, 1981
Magnetic field studies by voyager 1: preliminary results at saturnN F Ness, M H Acuña, R P Lepping, et al.Science (New York, N.Y.)|January 29, 1982
Magnetic field studies by voyager 2: preliminary results at saturnN F Ness, M H Acuna, K W Behannon, et al.DNA and Cell Biology|June 1, 1990
Molecular cloning of a novel bone-forming compound: osteoinductive factorL Madisen, M Neubauer, G Plowman, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Structure and chromosomal location of the human CD6 gene: detection of five human CD6 isoformsM A Bowen, G S Whitney, M Neubauer, et al.Molecular Pharmacology|April 1, 1995
Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contractionM L Webb, C C Chao, M Rizzo, et al.The Journal of Experimental Medicine|June 1, 1995
Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligandM A Bowen, D D Patel, X Li, et al.Diabetes Technology & Therapeutics|May 1, 2015
Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin TherapyLukas Schaupp, Klaus Donsa, Katharina M Neubauer, et al.Magnetic Resonance in Medicine|November 26, 2008
Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imagingAnne M Neubauer, Hoon Sim, Patrick M Winter, et al.International Journal of Nanomedicine|January 22, 2008
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeuticsTrung D Tran, Shelton D Caruthers, Michael Hughes, et al.Pageof 14